Posterior reversible encephalopathy syndrome due to malignant hypercalcemia: Physiopathological considerations

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1112-1116

  Camara Lemarroy, Carlos R ^a   Gonzalez Moreno, Emmanuel I ^a   De Jesus Ortiz Corona, Jose ^a   Yeverino Castro, Sara G ^a   Sanchez Cardenas, Monica ^a   Nuñez Aguirre, Sagrario ^a   Villarreal Alarcon, Miguel A ^a   Galarza Delgado, Dionicio A ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; HYPERCALCEMIA; PARANEOPLASTIC SYNDROMES; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 84898400989     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3487     Document Type: Article

References (31)

1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494-500.
2. Feske SK. Posterior reversible encephalopathy syndrome: a review. Semm Neurol. 2011;31:202-215.
3. Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Curr Opin Ophthalmol. 2008;19:479-484.
4. Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what's certain, what's new? Pract Neurol. 2011;11:136-144.
5. Bartynski WS. Posterior reversible encephalopathy syndrome. Part 2: controversies surrounding pathophysiology of vasogenic edema. Am J Neuroradiol. 2008;29:1043-1049.
6. Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28:1320-1327.
7. Frank Y, Pavlakis S, Black K, Bakshi S. Reversible occipital-parietal encephalopathy syndrome in an HIV-infected child. Neurology. 1998;51:915-916.
8. Kaplan PW. Reversible hypercalcemic cerebral vasoconstriction with seizures and blindness: a paradigm for eclampsia? Clin Elec-troencephalogr. 1998;29:120-123.
9. Kastrup O, Maschke M, Wanke I, Diener HC. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol. 2002;249:1563-1566.
10. Chen TH, Huang CC, Chang YY, Chen YF, Chen WH, Lai SL. Vasoconstriction as the etiology of hypercalcemia-induced seizures. Epilepsia. 2004;45:551-554.
11. Kim JH, Kim MJ, Kang JK, Lee SA. Vasogenic edema in a case of hypercalcemia-induced posterior reversible encephalopathy. Eur Neurol. 2005;53:160-162.
12. Choudhary M, Rose F. Posterior reversible encephalopathic syndrome due to severe hypercalcemia in AIDS. Scand J Infect Dis. 2005;37:524-526.
13. Au S, Dunham M, Godinez T. Treatment of medically refractory hypercalcemic crisis. Int J Artif Organs. 2012;35:538-541.
14. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol. 2000;21:1199-1206.
15. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neu-rol. 2008;65:205-210.
16. Edelson GW, Kleerekoper M. Hypercalcemic crisis. Med Clin North Am. 1995;79:79-92.
17. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227-239, vii.
18. Longo DL, Witherspoon JM. Focal neurologic symptoms in hypercalcemia. Neurology. 1980;30:200-201.
19. Walker GL, Williamson PM, Ravich RB, Roche J. Hypercalcaemia associated with cerebral vasospasm causing infarction. J Neurol Neurosurg Psychiatry. 1980;43:464-467.
20. Weiss-Guillet EM, Takala J, Jakob SM. Diagnosis and management of electrolyte emergencies. Best Pract Res Clin Endocrinol Metab. 2003;17:623-651.
21. Body JJ, Bouillon R. Emergencies of calcium homeostasis. Rev En-docr Metab Disord. 2003;4:167-175.
22. Santarpia L, Koch CA, Sarlis NJ. Hypercalcemia in cancer patients: pathobiology and management. Horm Metab Res. 2010;42:153-164.
23. Legrand SB. Modern management of malignant hypercalcemia. Am J Hosp Palliat Care. 2011;28:515-517.
24. Clines G. Mechanisms and treatment of hypercalcemia of malignancy. Curr Opin Endocrinol Diabetes Obes. 2011;18:339-346.
25. Camara-Lemarroy CR, Lara-Campos JG, Perez-Contreras E, Rodriguez-Gutierrez R, Galarza-Delgado DA. Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review. Clin Rheumatol. 2013;32:409-415.
26. Tatsumoto N, Fujisaki K, Nagae H, et al. Reversible posterior leu-koencephalopathy syndrome in a patient with severe uremic en-cephalopathy. Clin Nephrol. 2010;74:154-158.
27. Neunteufl T, Katzenschlager R, Abela C, et al. Impairment of en-dothelium-independent vasodilation in patients with hypercalce-mia. Cardiovasc Res. 1998;40:396-401.
28. Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hyper-calcemia. Surgery. 2001;130:986-990.
29. Rezic-Muzinic N, Cikes-Cuhc V, BozicJ, Ticinovic-Kurir T, Salamunic I, MarkoticcA. Hypercalcemia induces a proinflamma-tory phenotype in rat leukocytes and endothelial cells. J Physiol Biochem. 2013;69:199-205.
30. Shiraishi N, Kitamura K, Kohda Y, et al. Increased endothelin-1 expression in the kidney in hypercalcemic rats. Kidney Int. 2003;63:845-852.
31. Chen HI, Yeh DY, Kao SJ. The detrimental role of inducible nitric oxide synthase in the pulmonary edema caused by hypercalcemia in conscious rats and isolated lungs. J Biomed Sci. 2008;15:227-238.